Lifecore Biomedical, Inc. (LFCR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 272.08M |
| Enterprise Value | 397.22M |
| P/E Ratio | -3.72 |
| PEG Ratio | 0.3 |
| Price/Sales Ratio | 1.25 |
| Price/Book Ratio | 9.55 |
| Enterprise/Revenue | 2.37 |
| Enterprise/EBITDA | -70.36 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.3 |
| Operating Margin | -0.02 |
AD
Management Effectiveness
| Return On Assets | -0.16 |
| Return On Equity | -3.77 |
Income Statement
| Revenue | 129.46M |
| Revenue/Share | 3.26 |
| Gross Profit | 40.61M |
| EBITDA | 8.24M |
| Net Income | -30.79M |
| Diluted EPS | -0.93 |
Balance Sheet
| Total Cash | 17.24M |
| Total Cash/Share | 0.46 |
| Total Debt | 155.07M |
| Total Debt/Equity | 9.64 |
| Current Ratio | 3.87 |
| Book Value Per Share | 0.43 |
Price History
| 52-Week Change | -47.36 |
| 52-Week High | 8.98 |
| 52-Week Low | 3.63 |
| Moving Average 50 Days | 4.61 |
| Moving Average 200 Days | 5.9 |
Statistics
| Average Volume | 171,922 |
| Shares Outstanding | 37.51M |
| % Held by Institutions | 67.87 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
